4 Leukemia Clinical Trials in Providence, RI (2026)

Q: How do I join a clinical trial in Providence?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Providence research site will contact you.

Recruiting Leukemia Studies in Providence

NCT04968834Recruiting

Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens From Children And Young Adults With Hematologic Malignancy

This research study is a genomic profiling and repository study for children and young adults who have leukemia, myelodysplastic syndrome (MDS) or myeloproliferative syndrome (MPS). Genes are the part...

Providence, RI300 participantsDana-Farber Cancer Institute

View Study Details

NCT06119685Recruiting

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

This is an open label, Phase 1/2, first-in-human, multiple ascending dose, and dose-expansion study of IDP-023 administered as a single agent and in combination with or without interleukin-2 (IL-2), a...

Providence, RIPHASE1128 participantsIndapta Therapeutics, INC.

View Study Details

NCT05442216Recruiting

Tagraxofusp and Azaxitadine With or Without Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents

A treatment cycle is 28 days for Cycle 1 and Cycle 2. Tagraxofusp will be administered at 12 mcg/kg IV over 15 minutes (-5 or +15 minutes) daily for 5 consecutive days (or 5 doses over a period not to...

Providence, RIPHASE253 participantsJoshua Zeidner

View Study Details

NCT04933903Recruiting

BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab

This single-arm phase 2 study will enroll patients with resectable and operable stage IB - III non-small cell lung cancer and treat them with pre-operative ipilimumab + nivolumab plus low-dose stereot...

Providence, RIPHASE225 participantsBrown University

View Study Details

About Leukemia Clinical Trials in Providence

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 4 leukemia clinical trials recruiting participants in Providence, RI. These studies are seeking a combined 506 participants. Research is being sponsored by Dana-Farber Cancer Institute, Indapta Therapeutics, INC., Joshua Zeidner and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Providence — FAQ

Are there leukemia clinical trials in Providence?

Yes, there are 4 leukemia clinical trials currently recruiting in Providence, RI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Providence?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Providence research site will contact you about next steps.

Are clinical trials in Providence free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Providence studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 4 active trials in Providence are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated July 19, 2026 from ClinicalTrials.gov